SELESYN

This brand name is authorized in Hong Kong, Ireland, South Africa

Active ingredients

The drug SELESYN contains one active pharmaceutical ingredient (API):

1 Sodium selenite UNII HIW548RQ3W - SODIUM SELENITE

Selenium is an essential trace element. In human, selenium compounds are glutathione peroxidase and a selenium protein P found in the plasma. Deficiency of selenium has been associated with an endemic form of cardiomyopathy, Keshan disease and with Kaschin-Beck disease, an endemic osteoarthropathy which causes a severe deformity of the joints. Read about Sodium selenite

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SELESYN Solution for injection	Health Products Regulatory Authority (IE)	MPI, EU: SmPC
SELESYN Oral solution	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A12CE02	Sodium selenite	A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CE Selenium
Discover more medicines within A12CE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 63846, 63847, 63948
Country: ZA	Health Products Regulatory Authority	Identifier(s): 38/24/0441, A38/32.2/0442